ATE308318T1 - Trägerstoff zur verzögerten freisetzung - Google Patents

Trägerstoff zur verzögerten freisetzung

Info

Publication number
ATE308318T1
ATE308318T1 AT01112778T AT01112778T ATE308318T1 AT E308318 T1 ATE308318 T1 AT E308318T1 AT 01112778 T AT01112778 T AT 01112778T AT 01112778 T AT01112778 T AT 01112778T AT E308318 T1 ATE308318 T1 AT E308318T1
Authority
AT
Austria
Prior art keywords
delayed release
release carrier
cross
heteropolysaccharide
linking
Prior art date
Application number
AT01112778T
Other languages
English (en)
Inventor
Anand R Baichwal
Troy W Mccall
Original Assignee
Penwest Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penwest Pharmaceuticals Co filed Critical Penwest Pharmaceuticals Co
Application granted granted Critical
Publication of ATE308318T1 publication Critical patent/ATE308318T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Character Spaces And Line Spaces In Printers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Superstructure Of Vehicle (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Push-Button Switches (AREA)
AT01112778T 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung ATE308318T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23262594A 1994-04-25 1994-04-25

Publications (1)

Publication Number Publication Date
ATE308318T1 true ATE308318T1 (de) 2005-11-15

Family

ID=22873888

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95914917T ATE209906T1 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung
AT01112778T ATE308318T1 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT95914917T ATE209906T1 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung

Country Status (18)

Country Link
EP (2) EP1145712B1 (de)
JP (1) JP3279318B2 (de)
KR (1) KR100232020B1 (de)
CN (1) CN1131023C (de)
AT (2) ATE209906T1 (de)
AU (1) AU705378B2 (de)
CA (1) CA2164513C (de)
DE (2) DE69524358T2 (de)
DK (1) DK0706377T3 (de)
ES (2) ES2246961T3 (de)
FI (1) FI119353B (de)
HK (1) HK1040487B (de)
HU (1) HU219818B (de)
IL (1) IL113167A (de)
MX (1) MX9600022A (de)
PT (1) PT706377E (de)
TW (1) TW357085B (de)
WO (1) WO1995028916A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044952A1 (en) 1997-04-04 1998-10-15 Monsanto Company pH-SELECTIVE DELIVERY SYSTEM USING CROSS-LINKED POLYMERIC RESINS AS VEHICLES
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
WO1998044951A2 (en) * 1997-04-04 1998-10-15 Monsanto Company Hydrolysable delivery system using cross-linked polymeric resins as vehicles
US9820982B2 (en) 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
CA2459976A1 (en) * 2001-09-26 2003-04-03 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
CA2481091A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
KR101999055B1 (ko) * 2018-02-28 2019-10-01 경북대학교 산학협력단 과황산 이온 서방성 구조체, 이의 제조방법 및 이를 이용한 유기 오염 물질 처리 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303691A (en) * 1977-11-09 1981-12-01 Anderson, Clayton & Co. Proteinaceous food product
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form

Also Published As

Publication number Publication date
HK1040487A1 (en) 2002-06-14
ES2164764T3 (es) 2002-03-01
KR960703016A (ko) 1996-06-19
HK1040487B (en) 2006-05-12
KR100232020B1 (ko) 1999-12-01
FI119353B (fi) 2008-10-31
CN1131023C (zh) 2003-12-17
EP0706377B1 (de) 2001-12-05
HUT73636A (en) 1996-08-28
CA2164513C (en) 1999-09-21
CN1127469A (zh) 1996-07-24
AU2198295A (en) 1995-11-16
FI956209A0 (fi) 1995-12-22
ES2246961T3 (es) 2006-03-01
HU219818B (hu) 2001-08-28
HU9503456D0 (en) 1996-02-28
DK0706377T3 (da) 2002-04-02
IL113167A (en) 2001-01-28
PT706377E (pt) 2002-05-31
AU705378B2 (en) 1999-05-20
EP0706377A4 (de) 1996-11-06
CA2164513A1 (en) 1995-11-02
DE69524358D1 (de) 2002-01-17
JP3279318B2 (ja) 2002-04-30
FI956209L (fi) 1995-12-22
DE69534575T2 (de) 2006-07-13
MX9600022A (es) 1998-06-30
DE69534575D1 (de) 2005-12-08
EP1145712A1 (de) 2001-10-17
TW357085B (en) 1999-05-01
JPH08512061A (ja) 1996-12-17
EP0706377A1 (de) 1996-04-17
WO1995028916A1 (en) 1995-11-02
IL113167A0 (en) 1995-06-29
DE69524358T2 (de) 2002-06-13
EP1145712B1 (de) 2005-11-02
ATE209906T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
GR3021551T3 (en) Pharmaceutical composition containing terbinafine as an anti-mycotic agent
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
HUT75881A (en) Pharmaceutical composition for 24 hour release of metoprolol
GB2263115B (en) Composition for dental restoration
SG28285A1 (en) Method for molding dental restorations and related apparatus
BR9609537A (pt) Composições farmacêuticas
HUP9900625A3 (en) Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds
MX9603203A (es) Composiciones liquidas orales que contienen resinato de paroxetina.
FI905915L (fi) Tuggummikomposition.
ZA915717B (en) Benzimidazoles,pharmaceutical compositions containing these compounds and processes for preparing them
DE69523438D1 (de) Orale metoprolol-dosisform des typs "einmal täglich"
UA32543C2 (uk) Арилацетаміди, що мають анальгетичну дію, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
IL118426A0 (en) Pharmaceutical composition containing 1,3-bis-triazolyl-2- propanol derivative
IT1242170B (it) Composizione adesiva stabilizzante per protesi dentarie.
FR2627984B1 (fr) Composition pulverulente a base d'alginate pour empreintes dentaires
DE69326343D1 (de) Kaugummizusammensetzung
GB2292153B (en) Silicone composition for dental impressions
EP0461586A3 (en) Dental composition for impression-taking
ZA93196B (en) Composition for desensitizing teeth.
AU7550994A (en) Sustained release oral compositions containing melatonin
DE69524358D1 (de) Trägerstoff zur verzögerten freisetzung
DE59109272D1 (de) Mehrkomponentenmaterial und Verfahren zu seiner Herstellung
IL99501A0 (en) Interleukin 9 receptors,methods for the use thereof and pharmaceutical compositions containing the same
EP0515995A3 (en) N-(5-thioxo-l-prolyl)-l-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties